Caremark Looks Beyond Price Pressures From Retail, Health Plan-Owned PBMs
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite competition from “captive” pharmacy benefit managers, Caremark is expecting 8%-10% more revenue growth in 2006 than the current year.
You may also be interested in...
PBM-Owned Mail Order Pharmacies Do Not Result In Higher Costs – FTC
PDP sponsors generally paid less for drugs purchased through PBM-owned mail order pharmacies in 2002 and 2003 than for drugs purchased through mail-order or retail pharmacies not owned by PBMs, according to an FTC report.
Caremark Anticipates Modest Uptake For Medicare Rx Benefit In 2006
The PBM expects enrollment may not rise significantly until 2010 or later. Beneficiary participation in Part D could mirror the slow uptake of the drug discount card, CEO Crawford says, asserting that seniors "don't understand" the new benefit.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.